QOL Medical LLC
Travis Walter is an experienced pharmaceutical representative with a career spanning over two decades in the gastrointestinal and metabolic disorder sectors. Currently serving as a Senior GI Representative at QOL Medical LLC since March 2021, Travis has previously held the position of Territory Manager in the GI MED Division at Takeda Pharmaceuticals from June 2010 to October 2020, where notable products launched include Motegrity. Prior to this role, Travis worked at TAP Pharmaceuticals for ten years, where contributions included launching significant products such as Dexilant and Amitiza, and promoting Prevacid and its formulations. Travis holds a Bachelor's degree in Education from Virginia Tech.
This person is not in any offices
QOL Medical LLC
OL Medical is a specialty biopharmaceutical company dedicated to improving the quality of life for patients with rare diseases, for their families, and for the physicians and caregivers who support them.QOL Medical is a patient-centric company founded in 2003 to focus on the acquisition and commercialization of orphan products in underservedmarkets. QOL Medical ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of rare and orphan diseases. The Company currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (Ethanolamine Oleate) Injection, 5%.QOL Medical, in its commitment to assuring safe and effective products for our customers, uses validated procedures through audited and approved vendors for manufacturing, testing, and distribution. Additionally, QOL Medical has procedures for product monitoring, customer complaints, investigations into nonconformities, and change control.